Cost-effective BRCA Testing in Advanced Ovarian Cancer

참고문헌 (11)

1. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
2. 박보영, "Epidemiological characteristics of ovarian cancer in Korea", Journal of Gynecologic Oncology, 21(4), pp.241~247 (2010), 대한부인종양학회
3. Hunn J, "Ovarian cancer: etiology, risk factors, and epidemiology", Clin Obstet Gynecol, 55, pp.3~23 (2012)
4. 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2019", Cancer Research and Treatment, 51(2), pp.431~437 (2019), 대한암학회
5. Wright JD, "Trends in relative survival for ovarian cancer from 1975 to 2011", Obstet Gynecol, 125, pp.1345~1352 (2015)
6. George A, "Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer", Nat Rev Clin Oncol, 14, pp.284~296 (2017)
7. Colombo N, "Evaluation of a streamlined oncologist-led BRCA mutation testing and counseling model for patients with ovarian cancer", J Clin Oncol, 36, pp.1300~1307 (2018)
8. Anbok Lee, "BRCA1", BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies, 2020, pp.40(2), 114~121[DOI]
9. Lee A, "BRCA1", 2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients, 2019, pp.215, 152595~
10. Jaeeun Yoo, "Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome", Annals of Laboratory Medicine, 40(2), pp.148~154 (2020), 대한진단검사의학회[DOI]
11. Jang Jaehyeok, "Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer", Annals of Laboratory Medicine, 43(1), pp.73~81 (2023), 대한진단검사의학회[DOI]

관련 논문AI추천